Loss of bone mass and vitamin D deficiency after hematopoietic stem cell transplantation: Standard prophylactic measures fail to prevent osteoporosis

Leukemia

Volumn 15, Issue 11, 2001, Pages 1701-1705

  Massenkeil, G ^a   Fiene, C ^a   Rosen, O ^a   Michael, R ^a   Reisinger, W ^a   Arnold, R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Allogeneic stem cell transplantation; Bone mineral density; Osteoporosis; Vitamin D deficiency

Indexed keywords

AZATHIOPRINE; BIOCHEMICAL MARKER; CALCIUM; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PYRIDINIUM DERIVATIVE; STEROID; VITAMIN D;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ALLOTRANSPLANTATION; ANALYSIS; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; PROPHYLAXIS; SCORING SYSTEM; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 0035157998     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402264     Document Type: Article

References (26)

1. An update from the international bone marrow transplant registry and the autologous blood and marrow transplant registry on current activity in hematopoietic stem cell transplantation
2. Malignant neoplasms in long-term survivors of bone marrow transplantation
3. Modulation of osteoclast differentiation by local factors
4. Pluripotent hemopoietic stem cells give rise to osteoclasts
5. The origin of bone cells in the postnatal organism
6. Hemopoietic reconstitution after bone marrow transplantation
7. The response of bone to unloading
8. Bone density loss during treatment of chronic GVHD
9. Glucocorticoid-induced osteoporosis: Pathogenesis and management
10. Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation
11. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial
12. Reference values for trabecular and cortical vertebral bone density in single and dual-energy quantitative computed tomography
13. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis
14. Mechanisms of bone loss following allogeneic and autologous hematopoietic stem cell transplantation
15. Bone loss in long term survivors after transplantation of hematopoietic stem cells: A prospective study
16. Reduced bone density at completion of chemotherapy for a malignancy
17. Relative osteopenia after treatment for acute lymphoblastic leukemia
18. Bone mineral density in young adult survivors of childhood cancer
19. Lymphoblastoid interferon-alpha downregulates parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor expression in human osteoblastic cells (Saos-2)
20. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation
21. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry
22. High turnover bone disease following lung transplantation
23. Long-term medical complications in patients surviving > or = 5 years after liver transplant
24. Comparative metabolic activity in trabecular as against cortical osteoblasts
25. Influence of immobilization upon calcium metabolism in the week following hemiplegic stroke
26. 3 stimulates differentiation of committed murine bone marrow-derived macrophage percursor cells